Drugs / ABBV-932
Trials 10
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 17 trials | ||||||
| Phase 1 | NCT06953934 | May → Sep 2026 overdue | — | AbbVie | Active not recruiting | No outcome recorded |
| Phase 1 | NCT07024797 | Aug → Dec 2025 | — | AbbVie | Completed | No outcome recorded |
| Phase 1 | NCT07071532 | Jul → Nov 2025 overdue | — | AbbVie | Active not recruiting | No outcome recorded |
| Phase 1 | NCT06849791 | Feb 2025 → May 2026 | — | AbbVie | Completed | No outcome recorded |
| Phase 1 | NCT06300580 | Aug 2024 → May 2025 | — | AbbVie | Completed | No outcome recorded |
| Phase 1 | NCT06024239 | Aug 2023 → Mar 2025 | bipolar disorder, generalized anxiety disorder | AbbVie | Completed | No outcome recorded |
| Phase 1 | NCT05738850 | Feb 2023 → May 2024 | generalized anxiety disorder | AbbVie | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT07220460 | Sep 2025 → Apr 2027 expected | bipolar disorder | AbbVie | Recruiting | No outcome recorded |
| Phase 2 | NCT06846320 | Apr 2025 → Nov 2026 expected | generalized anxiety disorder | AbbVie | Recruiting | No outcome recorded |
| Phase 2 | NCT06605599 | Oct 2024 → Nov 2025 | bipolar I disorder, bipolar II disorder | AbbVie | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2026-04-29 | Gedeon Richter Ltd. | Results Update on Phase II study of ABBV-932 (RGH-932) for the treatment of bipolar depression gedeonrichter.com ↗
In the study, the overall difference observed between the drug-treated and placebo-treated groups was not statistically significant, however, in a pre-specified subgroup analysis of bipolar 1 patients, an efficacy signal was observed. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2026-04-29 | Gedeon Richter Ltd. | Update on Phase II study of ABBV-932 (RGH-932) for the treatment of bipolar depression gedeonrichter.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABBV-932 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06846320 ↗ |
| Route | Oral | “Oral Capsule” NCT05738850 ↗ |